Plot showing average position (centroid) of predatory behavior of 18 treatments displayed by snake <i>T</i>. <i>melanogaster</i>, depending of three categories (few, median, many)... by Javier Manjarrez (531011)

Image_6_Consecutive Hypoxia Decreases Expression of NOTCH3, HEY1, CC10, and FOXJ1 via NKX2-1 Downregulation and Intermittent Hypoxia-Reoxygenation Increases Expression of BMP4, NOT... by Yung-Yu Yang (9343376)

Image_5_Consecutive Hypoxia Decreases Expression of NOTCH3, HEY1, CC10, and FOXJ1 via NKX2-1 Downregulation and Intermittent Hypoxia-Reoxygenation Increases Expression of BMP4, NOT... by Yung-Yu Yang (9343376)

Image_8_Consecutive Hypoxia Decreases Expression of NOTCH3, HEY1, CC10, and FOXJ1 via NKX2-1 Downregulation and Intermittent Hypoxia-Reoxygenation Increases Expression of BMP4, NOT... by Yung-Yu Yang (9343376)

Image_7_Consecutive Hypoxia Decreases Expression of NOTCH3, HEY1, CC10, and FOXJ1 via NKX2-1 Downregulation and Intermittent Hypoxia-Reoxygenation Increases Expression of BMP4, NOT... by Yung-Yu Yang (9343376)

Immunohistochemical staining for endothelial cells (CD146) and astrocytes (GFAP) in the lumbar spinal cord of G93A mice at early and late stages of disease. by Svitlana Garbuzova-Davis (81764)

“…Scale bar in A, C, D, F is 50 µm; B, E, G is 25 µm.</p>…”

DataSheet1_v1_Insights Into Nickel Slag Carbonation in a Stirred Bead Mill.docx by Carine Julcour (5773055)

“…<p>This work is part of the ongoing development of the attrition-leaching carbonation process, a single-step aqueous carbonation technology that integrates a stirred bead mill. …”

Table 1_The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.docx by James P. Hardwick (20634155)

Image 3_The CYP4/20-HETE/GRP75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tif by James P. Hardwick (20634155)

Image 5_The CYP4/20-HETE/GRP75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff by James P. Hardwick (20634155)

Image 1_The CYP4/20-HETE/GRP75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff by James P. Hardwick (20634155)

Image 4_The CYP4/20-HETE/GRP75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff by James P. Hardwick (20634155)

Image 2_The CYP4/20-HETE/GRP75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff by James P. Hardwick (20634155)

Visual Detection of Speckles in the Fish <i>Xenotoca variata</i> by the Predatory Snake <i>Thamnophis melanogaster</i> in Water of Different Turbidity by Javier Manjarrez (531011)

Agreement with tolerance in the order of district towns in the results of SD-TOPSIS application in space ‐ combination A vs. D2. by Roman Vavrek (13200141)

MiR-125a inhibits cell proliferation and metastasis by directly targeting VEGF-A and MMP11. by Qian Bi (288827)

“…(D) qRT-PCR analysis shows that the VEGF-A and MMP11 mRNAs, but not others, were significantly decreased in HepG2-125a cells compared with HepG2-NC cells. …”

ACE phenotype for carriers of ACE mutations. by Olga V. Kryukova (19819428)

Localization of tested ACE mutations in the N and C domains of ACE. by Olga V. Kryukova (19819428)

The position of the mutations I989T, V992M and V997M in the ACE C domain. by Olga V. Kryukova (19819428)

Clinical examples of the normal controls, early glaucoma, and severe glaucoma. by Natalia Ivanovna Kurysheva (5679656)